• Shalom Kalnicki, MD, President of the RSS Board of Directors

• Brian D. Kavanagh, MD, MPH, FASTRO, University of Colorado, Aurora, CO

• Central Nervous System Session: Part 1
  Clinical Abstract Presentations with Q&A

  7:50 - 7:59 am	Interactions between Dose, Cavity Size, and Histology in the Prediction of Local Control following Stereotactic Radiosurgery for Resected Brain Metastases Chengcheng Gui, BSE, Johns Hopkins University School of Medicine, Baltimore, MD
  8:00 - 8:09 am	Tumor Control and Survival in Patients with Ten or More Brain Metastases Treated with Stereotactic Radiosurgery: A Retrospective Analysis Matthew Ehrlich, BS, Northwell Health, Hempstead, NY
  8:10 - 8:19 am	Management of Brain Metastases from Large Cell Neuroendocrine Carcinoma of the Lung: Improved Outcomes with Radiosurgery Shaakir Hasan, DO, Allegheny Health Network, Pittsburgh, PA
  8:20 - 8:29 am	High-Grade Toxicity after Combination Radiosurgery Anti-PD-1 Immunotherapy for Brain Metastases Roman Travis, BS, The University of Alabama at Birmingham School of Medicine, Birmingham, AL
  8:30 - 8:39 am	Dosimetric Comparison of Protons versus Photons for Treatment of Pituitary Adenoma Shivani Sud, MD, Massachusetts General Hospital, Boston, MA
  8:40 - 8:49 am	Primary and Repeat Linac Radiosurgery for Cerebral Arteriovenous Malformations in Pediatric Population Slawomir Blamek, MD, PhD, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
  8:50 - 9:00 am	Q&A - CNS Session: Part 1

• Central Nervous System Session: Part 2
  Clinical Abstract Presentations with Q&A

  9:00 - 9:09 am	Systemic Therapy as a Risk Factor Associated to Complications in SBRT for Spine Metastases Christian Arias, MD, Centre Hospitalier De L'Université De Montréal, Montréal, Quebec, Canada
  9:10 - 9:19 am	Initial Observation of Vestibular Schwannomas: A Modern Institutional Experience Aditya Patibandla, BS, Mayo Clinic, Rochester, MN
  9:20 - 9:29 am	Clinic Feasibility of Frameless Functional Radiosurgery with a Virtual Cone John Fiveash, MD, University Alabama at Birmingham Hospital, Birmingham, AL
  9:30 - 9:39 am	The Dancing Cord: Inherent Spinal Cord Motion and Its effect on Cord Dose in Spine Stereotactic Body Radiation Therapy Murat Alp Oztek, MD, University of Washington Medical Center, Seattle, WA
  9:40 - 9:49 am	Therapeutic Effect of Fractionated CyberKnife Radiosurgery for High Volume Huge Cavernous Sinus Cavernous Hemangioma Lichao Huang, MD, PLA General Hospital, Beijing, China
  9:50 - 10:00 am	Q&A - CNS Session: Part 2

• SRS/SBRT for Clinical Applications
  Clinical Abstract Presentations with Q&A

  10:30 - 10:39 am	Dose-Response Modeling the Risk of Carotid Bleeding Events after Stereotactic Body Radiation Therapy for Previously-Irradiated Head and Neck Cancer Diane C. Ling, MD, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA
  10:40 - 10:49 am	Unconventional SBRT-Based Partial Irradiation of Unresectable Bulky Tumors exploiting the Bystander and Abscopal Effects Slavisa Tubin, MD, KABEG Klinikum Klagenfurt, Klagenfurt, Austria
  10:50 - 10:59 am	Trends of Stereotactic Body Radiation Therapy Utilization in the United States from 2004-2015 Eric Lehrer, MD, MS, Northwell Health - Mather Hospital, Port Jefferson, NY
  11:00 - 11:09 am	Long-Term Results of Stereotactic Thermal Destruction Drug-Resistant Temporal Lobe Epilepsy Elena Slobina, MD, PhD, Russian Scientific Center of Roentgenoradiology, Moscow, Russia
  11:10 - 11:20 am	Q&A - Other Categories Session

• Thoracic Session
  Clinical Abstract Presentations with Q&A

  11:20 - 11:29 am	Clinical Outcomes following Stereotactic Body Radiation Therapy (SBRT) for Small-Cell Lung Carcinoma: A Preliminary Analysis from The RSSearch® Patient Registry Raj Singh, MD, Virginia Commonwealth University, Richmond, VA (1); Mather Hospital, Port Jefferson, NY (2)
  11:30 - 11:39 am	Stereotactic Body Radiotherapy for Pulmonary Non-Small Cell Neuroendocrine Tumors Anand Mahadevan, MD, Geisinger Cancer Institute- Geisinger Health, Danville, PA
  11:40 - 11:49 am	Early Feasibility Study for Cardiac Radiosurgery: Evaluation of Novel 3-D Treatment Planning Software and Safety Data on First Three Patients Brad Pollard, MS, Austin CyberKnife, Austin, TX
  11:50 am - 12:00 pm	Q&A - Thoracic Session

• Genitourinary Session
  Clinical Abstract Presentations with Q&A

  1:30 - 1:39 pm	Ten-Year Final Results of the TROG 03.04 (Radar) Randomised Phase 3 Trial with an Analysis of the Relative Benefit of Radiation Dose Escalation and Longer Hormone Duration to Prevent Distant Progression with Locally Advanced Prostate Cancer David Joseph, MD, MBBS, FRANZCR, MRACMA, 5D Clinics, Perth, WA, Australia
  1:40 - 1:49 pm	Ten-Year Final Results of the TROG 03.04 (Radar) Randomised Phase 3 Trial evaluating Duration of Androgen Suppression ± Zoledronate for Locally Advanced Prostate Cancer David Joseph, MD, MBBS, FRANZCR, MRACMA, 5D Clinics, Perth, WA, Australia
  1:50 - 1:59 pm	Outcomes of Stereotactic Body Radiotherapy delivered by Gantry-Based Linear Accelerators for Low- and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Study Audrey Dang, MD, UCLA, Los Angeles, CA
  2:00 - 2:09 pm	Implications for Appropriate Margins in Radiosurgery of Bone Oligometastases from Prostate Cancer: An Analysis of Sodium Flouride (NaF) PET/CT Response Assessment in the POPSTAR Clinical Trial Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia
  2:10 - 2:19 pm	Continence and Voiding Outcomes after Stereotactic Body Radiation in Prostate Cancer Patients with Prior Trans Urethral Resection of Prostate Lee McNeely, MD, Anova Cancer Care, Lone Tree, CO
  2:20 - 2:29 pm	Utilization of Stereotactic Body Radiation Therapy for Localized Prostate Cancer at Georgetown University Hospital: An Analysis of Patient Demographics and Travel Distance Nima Aghdam, MD, Georgetown University Hospital, Washington, DC
  2:30 - 2:45 pm	Q&A - Genitourinary Session

• Gastrointestinal Session
  Clinical Abstract Presentations with Q&A

  2:45 - 2:54 pm	Stereotactic Body Radiotherapy (SBRT) for Colorectal Liver Metastasis - Clinical Outcomes from the International Multi-Institutional RSSearch® Patient Registry Pollyanna Leite, MD, Guy's Hospital, London, UK
  2:55 - 3:04 pm	Adjuvant Pancreatic SBRT for Close or Positive Margins Philip Sutera, BS, UPMC Hillman Cancer Center, Pittsburgh, PA
  3:05 - 3:14 pm	Stereotactic Body Radiation Therapy with Immunotherapy in the Treatment of Oligometastatic Disease: A Subset Analysis of a Prospective Phase II Trial Philip Sutera, BS, UPMC Hillman Cancer Center, Pittsburgh, PA
  3:15 - 3:24 pm	Prognostic Factors for SBRT in Pancreatic Cancer: Analysis of the Multi-Institutional RSSearch® Patient Registry Database Amanda Rivera, MD, Montefiore Medical Park, Bronx, NY
  3:25 - 3:34 pm	Real-Time Magnetic Resonance Guided Liver Stereotactic Body Radiation Therapy Aharon Feldman, MD, Henry Ford Health System, Detroit, MI
  3:35 - 3:44 pm	Liver Function Abnormalities Twelve Months after Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) Justin Tang, MD, Montefiore Medical Park, Bronx, NY
  3:45 - 4:00 pm	Q&A - Gastrointestinal Session

• Physics Abstract Presentations with Q&A: Part 1

  8:00 - 8:14 am	Real-Time Target Tracking in Pancreatic SBRT: Characterizing the Clinical Impact Bernard Jones, PhD, University of Colorado, Denver, CO
  8:15 - 8:29 am	Determination of Treatment Margins for Head and Neck Tumors Treated with a Robotic Radiosurgery System using Spine or Skull Tracking Justin Hurley, University of Louisville Brown Cancer Center, Louisville, KY
  8:30 - 8:44 am	Dose Discrepancy of External SRS Audit - Investigation of Linac Deliverability Factors Kirsty Blythe, PhD, Guy's and St Thomas NHS Foundation Trust, London, UK
  8:45 - 8:59 am	Determining the Spatial Accuracy of Frameless Linac-Based Radiosurgery for Trigeminal Neuralgia Daphne Levin, PhD, Assuta Medical Centers, Tel Aviv, Israel
  9:00 - 9:14 am	Comparison of Surrogate Matching Methods for Target Localization with Free-Breathing in Stereotactic Body Radiation Treatment for Liver Tumors Shilby Paul, MD, PhD, Montefiore Medical Center, Bronx, NY
  9:15 - 9:29 am	Evaluation of a Novel Streamlined Solution for MLC-Based Intracranial SRS Everardo Flores-Martinez, PhD, University of San Diego, San Diego, CA
  9:30 - 9:44 am	SRS Quality Assurance Using Real-Time Optical Imaging Muhammad Ramish Ashraf, BS, Dartmouth College, Hanover, NH
  9:45 - 10:00 am	Towards Application of Cone Beam CT Dosimetry (CBCT-D) to Multifocal SRS End-to-End Testing Justus Adamson, PhD, Duke University, Durham, NC

• Physics Abstract Presentations with Q&A: Part 2

  10:30 - 10:44 am	Plan Quality Control for Single Isocenter Multiple Target Radiosurgery with a Knowledge-Based Optimization Model Yun Yang, PhD, Duke University, Durham, NC
  10:45 - 10:59 am	Profile Comparisons of Small Dose Volumes between Three Radiosurgery Systems Steve Sorensen, PhD, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ
  11:00 - 11:14 am	A Comparison of Intracranial Gross Tumor Volumes Generated on MPRAGE and VIBE MR Protocols Amelia Wexler, MS, University of Missouri, Columbia, MO
  11:15 - 11:29 am	Dose Discrepancy of External UK SRS Audit - Investigation of Planning Factors Kirsty Blythe, PhD, Guy's and St Thomas NHS Foundation Trust, London, UK
  11:30 - 11:44 am	Monte Carlo Commissioning for CyberKnife Multileaf Collimator and Proposed Acceptance Criteria Tatsiana Reynolds, PhD, Minnesota Oncology, Minneapolis, MN
  11:45 am - 12:00 pm	A Beam Applicator for Radiosurgery of the Eye using a Scanning Ion Beam Delivery System Michael Moyers, PhD, Shanghai Proton and Heavy Ion Center, Shanghai, China

Artificial Intelligence and Quantitative Analysis Perspective on Radiation Oncology and SRS/SBRT Session

Moderators:

• Stanley H. Benedict, PhD, FAAPM, University of California, Davis, Davis, CA
• Timothy D. Solberg, PhD, FACR, FACMP, FAAPM, FASTRO, University of California, San Francisco, San Francisco, CA
• Fang-Fang Yin, PhD, Duke University, Durham, NC

Current and future Artificial Intelligence in Radiation Oncology and SRS/SBRT
Jackie Wu, PhD, Duke University, NC

The Future of Quantitative Imaging in Radiation Oncology and SRS/SBRT
Olivier Morin, PhD, University of California, San Francisco, CA

Quality Assurance as It Relates to Various Treatment Systems

Moderators:

• Grace Kim, PhD, University of California, San Diego, San Diego, CA
• Christoph Fürweger, PhD, European CyberKnife Center, Munich, Germany

Quality Assurance for MR-Guided Radiosurgery
James Balter, PhD, University of Michigan, Ann Arbor, MI

The Benefits of Monte Carlo-Based Secondary Dose Calculation in a Comprehensive QA Solution
Markus Alber, PhD, Heidelberg University, Heidelberg, Germany

IROC’s External Quality Assurance Audits for Radiosurgery
Stephen F. Kry, PhD, MD Anderson Cancer Center, Houston, TX

• Tumor Control Probability Guidelines for SRS/SBRT

  As an evolving treatment modality in both the primary and recurrent setting, stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) is increasingly being used worldwide. It is well-recognized that the radiobiology of radiosurgery and its associated outcomes for a variety of tumor types remains a “works-in-progress.” In the Tumor Control Probability Guidelines” session, we will present the “state of the science” by recognized experts in the field of lung, head & neck and spine.

Moderator:

• Dwight E. Heron, MD, MBA, FACRO, FACR, UPMC Hillman Cancer Center, Pittsburgh, PA

Overview of Tumor Control Probability Guidelines
Jimm Grimm, PhD, Johns Hopkins Medical Center, Baltimore MD

SABR/SBRT for Lung - Tumor Probability Guidelines
Percy P. Lee, MD, David Geffen School of Medicine, UCLA; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA

Radiosurgery for Spine - Tumor Probability Guidelines
Scott Soltys, MD, Stanford University Medical Center, Stanford, CA

SABR/SBRT for Head & Neck - Tumor Probability Guidelines
Andy Clump, MD, PhD, UPMC Hillman Cancer Center, Pittsburgh, PA

“March Madness” Reception

• Mix and Mingle Evening Event
• Poster Presentations
• Walk With A Professor Poster Walk
• Award Presentations

Current and Future Approaches to Combining Immunotherapy & Radiosurgery

A joint session hosted by the Radiosurgery Society (the RSS) in collaboration with the Society for Immunotherapy of Cancer (SITC).

Session Chairs:

• Mansoor M. Ahmed, PhD, National Cancer Institute/National Institutes of Health, Rockville, MD
• Marka Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

Opening Remarks
Mansoor M. Ahmed, PhD, National Cancer Institute/National Institute of Health, Rockville, MD

Cancer Immunology / Immunotherapy: A Primer for Radiation Oncologists & Medical Physicists
Alice O. Kamphorst, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Opportunities and Challenges of Combining SBRT and Immunotherapy
Stephen L. Shiao, MD, PhD, Cedars-Sinai Medical Center and University of California, Los Angeles, Los Angeles, CA

Combining Interleukin-2 and SBRT for Melanoma
Marka R. Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

FLT3 Ligand and SBRT for Lung Cancer
Chandan Guha, MBBS, PhD, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Combination Immunotherapy and SBRT for Head & Neck Cancer
Nadeem Riaz, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Closing Remarks
Marka R. Crittenden, MD, PhD, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR

• Recent Developments in SRS for Functional Diseases

  Brain science continues to evolve and along with it so must diagnoses and treatment options. Optimizing patient care by combining clinical and technological breakthroughs; incorporating artificial intelligence and brain-fusion techniques; and collaboration with innovation are critical to advancing functional neurological treatment breakthroughs. This session will highlight the advancements in the treatment of Parkinson’s Disease, Epilepsy, Trigeminal Neuralgia, Obsessive Compulsive Disorders and Essential Tremors using Stereotactic Radiosurgery from a few of the world’s leading neurosurgeons.

Moderators:

• Michael Schulder, MD, FAANS, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
• Pantaleo Romanelli, MD, CyberKnife Center, CDI, Milano, Italy

SRS for Obsessive Compulsive Disorder
David Mathieu, MD, FRCS(C), Université de Sherbrooke, Sherbrooke, Qc, Canada

SRS for Parkinson’s and Epilepsy
Sameer Seth, MD, PhD, Baylor College of Medicine, TX

SRS for Trigeminal Neuralgia
Konstantin V. Slavin, MD, University of Illinois at Chicago, Chicago, IL

SRS vs Focused Ultrasound
Casey Halpern, MD, Stanford University Medical Center, Stanford, CA

• Building Collaborative Teams – Exchanging Experiences and Addressing Challenges

  This interactive session will give attendees direct access to those who have survived (and thrived) the growing-pains of building successful SRS/SBRT programs. Topics will include administrative strategic growth, incorporating academic research processes, utilizing the RSSearch patient registry, economic program development, cultivating a harmonious multi-disciplinary culture and how to navigate the introduction of new technologies and programs.

  Attendees will be given the opportunity throughout the session to present questions and experiences faced within their own institutions to be addressed by a panel of experts of all specialties.

Moderator:

• Brian D. Kavanagh, MD, MPH, FASTRO, University of Colorado, Aurora, CO

Session Chairs:

• Iris Gibbs, MD, Stanford Medical Center
• Shalom Kalnicki, MD, Montefiore Medical Center/Albert Einstein College of Medicine
• Simon Lo, MD, University of Washington
• Susan Pannullo, MD, FAANS, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
• Michael Schulder, MD, FAANS, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY

Expert Panelists:

• Iris Gibbs, MD, and Laurie Tupper, NP-C, AOCNP, Stanford Medical Center
• Dwight Heron, MD, and Annette Quinn, RT, UPMC Hillman Cancer Centers
• Shalom Kalnicki, MD, Montefiore Medical Center/Albert Einstein College of Medicine
• Simon Lo, MD, University of Washington
• Anand Mahadevan, MD, Geisinger Health System
• Susan Pannullo, MD, FAANS, and Jonathan Knisely, MD, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
• Michael Schulder, MD, FAANS, and Anuj Goenka, MD, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY

Debate I: SRS vs Whole Brain Radiation Therapy for Brain Metastases - Is SRS a Slam Dunk for Brain Metastases?

Presented by:

• Hany Soliman, MD, FRCPC, Assistant Professor, University of Toronto, Toronto, Canada
• Mark V. Mishra, MD, University of Maryland Medical System, Baltimore, MD

Debate II: SBRT vs Focal Ablation Therapy for Primary Renal Cell Carcinoma – Let the Madness Begin

Presented by:

• Robert Abouassaly, MD, Cleveland Clinic, Cleveland, OH
• Shankar Siva, PhD, MBBS, FRANZCR, Sir Peter MacCullum Cancer Center, Melbourne, Australia

Concurrent Sessions:

• RSSearch^® Patient Registry Breakout
• Residents’ Breakout

Performance & Quality Improvement Session (PQIS) with Case-Based Discussions

Individual case presentations based on submissions.

Moderators:

• Richard D. Bucholz, MD, FACS, St. Louis University Hospital Medical Center, St. Louis, MO
• John J. Kresl, MD, PhD, DABR, FACR, FACRO, Phoenix CyberKnife & Radiation Oncology Center, Phoenix, AZ

This session is restricted – no guest, commercial vendors, exhibitor or staff will be allowed into the room.

The Powerpoint presentation template may be downloaded here.

Dosimetry Plan Study – SBRT for Pancreatic Cancer

Announcement and presentations of top performing submitted cases.

A joint session hosted by the Radiosurgery Society (the RSS) in collaboration with the American Association of Medical Dosimetrists (AAPM)

Session Chair:

• Anand Mahadevan, MD, Geisinger Medical Center, Danville, PA

Expert Panelists:

• Steve Burton, MD, UPMC Hillman Cancer Center, Pittsburg, PA
• Daniel Chang, MD, Stanford University Medical Center, Stanford, CA
• Amol Narang, MD, Johns Hopkins Medicine, Baltimore, MD
• Brian Wang, PhD, University of Louisville, Louisville, KY
• Grace Kim, PhD, University of San Diego, San Diego, CA

Individual Case Presentations based on Submissions

Didactic Session (no charge to attend)

• Lung SABR/SBRT Workshop: Current Challenges and Future Directions

  The RSS will be holding a special lecture series and hands-on workshop focused on the current challenges of lung stereotactic body radiotherapy (SBRT) treatment planning and delivery, the conundrum of post SBRT follow up imaging and recommended practices and updates from the clinical trials on SBRT for early-stage operable lung cancer. The session will also explore single fraction radiosurgery for thoracic tumors and future indications for lung SBRT. The lecture series will be open to all registered 2019 RSS Scientific Meeting attendees. The Hands-On Workshop will be held immediately after the lecture series and will focus on clinical case discussions, contouring, treatment planning tips and tricks by the expert panel and demonstrations by various Corporate Vendors. There is an additional registration fee for the Hands-On Workshop and limited attendance.

Session Chairs:

• Drew Moghanaki, MD, Atlanta Veterans Affairs Healthcare Systems, Emory University School of Medicine, Decatur, GA
• Ben J. Slotman, MD, PhD, FACR, VU University Medical Center, Amsterdam, Netherlands

SABR for Operable Stage I NSCLC: Lessons Learned from the VALOR Trial
Drew Moghanaki, MD, Atlanta Veterans Affairs Healthcare Systems, Emory University School of Medicine, Decatur, GA

Evolving Paradigms for Lung SBRT
Pam Samson, MD, Washington University, St. Louis, MO

The Conundrum of Post-SBRT Thoracic Imaging
Ben J. Slotman, MD, PhD, FACR, VU University Medical Center, Amsterdam, Netherlands

SBRT for Metastatic Lung Cancer
Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia

Lung SABR/SBRT Hands-On Workshop*

Moderator:

• Brian Wang, PhD, University of Louisville, Louisville, KY

Common Mistakes with Lung SBRT: Lessons from LUSTRE
Anand Swaminath, MD, MacMaster University, Hamilton, Canada

Vendor Station Rotations and Presentations:
Clinical cases, treatment planning tips and tricks, and pearls and pitfalls. Attendees will have 20-minute rotations to learn and interact with Corporate Vendors and Expert Panelists.

Expert Panelists:

• Pam Samson, MD, Washington University, St. Louis, MO
• Anand Swaminath, MD, McMaster University, Hamilton, Canada
• Drew Moghanaki, MD, Atlanta Veterans Affairs Healthcare Systems, Emory University School of Medicine, Decatur, GA
• Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia

* There is an additional registration fee to attend this hands-on workshop.

RSS Members: $55.00
Non-RSS Members: $85.00